Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Non-Current Deffered Revenue: 2011-2012

Historic Non-Current Deffered Revenue for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Dec 2012 value amounting to $3.0 million.

  • Sonoma Pharmaceuticals' Non-Current Deffered Revenue rose 2028.57% to $3.0 million in Q4 2012 from the same period last year, while for Dec 2012 it was $3.0 million, marking a year-over-year increase of 2028.57%. This contributed to the annual value of $133,000 for FY2012, which is 16.87% down from last year.
  • Latest data reveals that Sonoma Pharmaceuticals reported Non-Current Deffered Revenue of $3.0 million as of Q4 2012, which was down 11.04% from $3.4 million recorded in Q3 2012.
  • In the past 5 years, Sonoma Pharmaceuticals' Non-Current Deffered Revenue ranged from a high of $3.4 million in Q3 2012 and a low of $126,000 during Q2 2012.
  • Its 2-year average for Non-Current Deffered Revenue is $898,750, with a median of $150,500 in 2011.
  • The largest annual percentage gain for Sonoma Pharmaceuticals' Non-Current Deffered Revenue in the last 5 years was 2,178.91% (2012), contrasted with its biggest fall of 18.18% (2012).
  • Sonoma Pharmaceuticals' Non-Current Deffered Revenue (Quarterly) stood at $140,000 in 2011, then soared by 2,028.57% to $3.0 million in 2012.
  • Its Non-Current Deffered Revenue stands at $3.0 million for Q4 2012, versus $3.4 million for Q3 2012 and $126,000 for Q2 2012.